A Novel SARS-CoV-2-Derived Infectious Vector System
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of COVID-19. The development of antiviral drugs for COVID-19 has been hampered by the requirement of a biosafety level 3 (BSL3) laboratory for experiments related to SARS-CoV-2, and by the lack of easy and precise me...
Saved in:
| Main Authors: | Ghada Elfayres, Yong Xiao, Qinghua Pan, Chen Liang, Benoit Barbeau, Lionel Berthoux |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Series: | Microbiology Research |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2036-7481/16/6/125 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Novel Toolkit of SARS-CoV-2 Sub-Genomic Replicons for Efficient Antiviral Screening
by: Maximilian Erdmann, et al.
Published: (2025-04-01) -
Dimming the corona: studying SARS-coronavirus-2 at reduced biocontainment level using replicons and virus-like particles
by: Grace Neilsen, et al.
Published: (2024-12-01) -
Identification of potential SARS-CoV-2 inhibitors among well-tolerated drugs using drug repurposing and in vitro approaches
by: Betül Oruçoğlu, et al.
Published: (2025-04-01) -
SARS-CoV-2 Replication Revisited: Molecular Insights and Current and Emerging Antiviral Strategies
by: Bryan John J. Subong, et al.
Published: (2025-05-01) -
Durability of immune response against omicron BA.2 and BA.4/5 and T cell responses after boosting with mRNA and adenoviral vector-based vaccines following heterologous CoronaVac/ChAdOx-1nCov-19 vaccination
by: Nungruthai Suntronwong, et al.
Published: (2023-12-01)